Tag: Drug

Diabetic Retinopathy Drug Market Analysis 2020-2025 by Technological Advancements, Business Analysis Top Companies, Demand Forecast

The MarketWatch News Department was not involved in the creation of this content.

Sep 21, 2020 (AmericaNewsHour) —
Diabetic retinopathy is a medical condition which damages retina (present at the back of eye) and leads to blindness if untreated or undiagnosed. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the disease at its initial stage.

The global diabetic retinopathy drug market is anticipated to bolster at a robust growth rate to reach USD 705 Million by 2025. Geographically, the global diabetic retinopathy drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of World.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Regional Market).”

Request To Fill The form for a Sample Copy of This Report:https://www.kennethresearch.com/sample-request-10075281

Market Segmentation

By

Read More

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

SHANGHAI, Sept. 20, 2020 /PRNewswire/ — Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as “Viva Biotech” or “The Company”) entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong) Limited (hereinafter referred to as ” SYNthesis “), at the consideration of approximately US$ 80 million (equivalent to approximately HK$ 620 million). The acquisition will achieve the synergies between Viva Biotech and SYNthesis, regarding to the CRO business in the global market, which is of great strategic significance for The Company to conduct vertical integration and establish a comprehensive one-stop drug services platform.

SYNthesis is a preclinical small molecule drug discovery service contract organisation which mainly provides high-end pharmaceutical chemistry and synthetic chemistry services to its clients. SYNthesis is headquartered in Hong

Read More

Global Central Nervous System Diseases Drug Delivery Technologies, Markets & Companies Research Report 2020 – ResearchAndMarkets.com – Press Release

DUBLIN–(Business Wire)–The “Drug Delivery in Central Nervous System Diseases – Technologies, Markets & Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering.

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g., by intravenous injection) for targeted action in the CNS. The major challenge to CNS drug delivery is the blood-brain barrier (BBB), which limits the access of drugs to the brain substance.

Advances in understanding of the cell biology of the BBB have opened new avenues and possibilities for improved drug delivery to the CNS. Several carrier or transport systems, enzymes, and receptors that control the penetration of molecules have been identified in the BBB endothelium. Receptor-mediated transcytosis can transport peptides and proteins across the BBB. Methods are available to assess the BBB permeability of drugs at

Read More

Diabetes Drug Market Demand Status 2020 Share, Global Trend, Industry News, Size, Business Growth, Top Key Players Update by Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 18, 2020 (The Expresswire) —
Global “Diabetes Drug Market” report gives a historical overview of the Diabetes Drug market trends, growth, revenue, capacity, cost structure, and key driver’s analysis. The report further investigates and assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the Diabetes Drug market. Report covers the current status of the market including Internal Nasal Dilators market size, growth rate, prominent players, and current competitive landscape. It also analyses future opportunities and forecasts the market assessing the strategies of the key players in terms of merger and acquisitions, investments, technological advancements.

Get Sample PDF of the report at – https://www.marketreportsworld.com/enquiry/request-sample/15514002

● In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

Read More

S.Africa’s Aspen sells thrombosis drug business to Mylan, shares jump

Adds details

JOHANNESBURG, Sept 8 (Reuters)South African drugmaker Aspen Pharmacare APNJ.J has agreed to sell the rights to its European thrombosis business to U.S. pharmaceutical company Mylan MYL.O for almost 642 million euros ($759 million), sending its shares up 7% on Tuesday.

“The transaction supports Aspen’s strategy of continuing to reshape the Group towards a greater concentration of revenue in emerging markets,” Aspen said in a statement.

The company said it would retain the thrombosis business almost exclusively in emerging markets.

The sale will also allow Aspen to streamline its business in Europe, strengthen its balance sheet and provide “financial headroom” for future investments, the company said.

Proceeds from the deal will be used to reduce the group’s debt, Aspen said, adding Mylan would pay 263.2 million euros on completion of the deal and the balance in June 2021.

Investors have been concerned about Aspen’s debt in

Read More

Nasal Drug Delivery Market Trends, Business Opportunities, Challenges, Size, Share, Growth Insights to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 08, 2020 (The Expresswire) —
The global “Nasal Drug Delivery Market Size” is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.

The report covers:

  • Global Nasal Drug Delivery Market trends, with detailed
Read More

Asia Pacific $15.78 Bn Antibiotics Market Forecast to 2027: COVID-19 Impact and Regional Analysis by Drug Class & Action Mechanism – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Antibiotics Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country” report has been added to ResearchAndMarkets.com’s offering.

The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 million by 2027 from US$ 11,591.97 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027.

The antibiotics market is growing primarily due to prevalence of infectious diseases and consolidated government initiatives in emerging economies of Asia Pacific region. The tedious and expensive process of antibiotic development is likely to damage the growth of the market in the coming years. Additionally, growing investments to combat antimicrobial resistance and incorporation of novel computing technologies for antibiotics discovery are likely to increase the growth of the Antibiotics market during the forecast period.

Antibiotics refer to a class of medicines containing substances that

Read More